Immuneering CEO Ben Zeskind Discusses Cancer Immunotherapy at ASCO 2013

June 2, 2013 – Immuneering CEO Ben Zeskind was interviewed during the 2013 ASCO Annual Meeting as part of a series of videos produced by the Society for Immunotherapy of Cancer (SITC), featuring experts in cancer immunotherapy.